BNGO - Bionano Genomics Inc
IEX Last Trade
0.4897
0.007 1.327%
Share volume: 753,150
Last Updated: Fri 30 Aug 2024 09:58:01 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$0.48
0.01
1.35%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-09 | 2023-05-09 | 2023-08-09 | 2023-11-08 | 2024-03-05 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 321.552 M | 323.698 M | 307.502 M | 292.151 M | 271.381 M | 181.904 M | 214.404 M | 157.995 M | |
| Current Assets | 216.288 M | 218.197 M | 157.298 M | 142.557 M | 122.575 M | 104.537 M | 140.118 M | 85.611 M | |
| Inventories | 20.591 M | 25.046 M | 29.761 M | 33.113 M | 32.453 M | 26.429 M | 22.892 M | 19.587 M | |
| Other Current Assets | 3.509 M | 7.132 M | 7.329 M | 6.856 M | 5.447 M | 5.857 M | 6.019 M | 4.945 M | |
| Short Term Investments | 3.509 M | 7.132 M | 7.329 M | 6.856 M | 5.447 M | 5.857 M | 6.019 M | 4.945 M | |
| Total Receivables | 4.851 M | 5.829 M | 7.022 M | 6.780 M | 7.613 M | 8.669 M | 9.319 M | 8.313 M | |
| Current Cash | 187.337 M | 180.190 M | 113.186 M | 95.808 M | 77.062 M | 63.582 M | 66.771 M | 28.320 M | |
| Total Non-current Assets | 105.264 M | 105.501 M | 150.204 M | 149.594 M | 148.806 M | 77.367 M | 74.286 M | 72.384 M | |
| Property Plant Equipment | 13.923 M | 15.859 M | 18.029 M | 19.050 M | 20.263 M | 21.266 M | 23.345 M | 25.279 M | |
| Other Assets | 11.082 M | 10.591 M | 13.343 M | 13.504 M | 13.303 M | 19.935 M | 16.567 M | 14.971 M | |
| Intangible Assets | 24.005 M | 22.585 M | 41.143 M | 39.351 M | 37.559 M | 35.766 M | 33.974 M | 31.734 M | |
| Goodwill | 56.254 M | 56.466 M | 77.289 M | 77.289 M | 77.281 M | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 321.552 M | 323.698 M | 307.502 M | 292.151 M | 271.381 M | 181.904 M | 214.404 M | 157.995 M | |
| Total liabilities | 36.818 M | 41.956 M | 58.104 M | 60.664 M | 56.625 M | 62.905 M | 118.247 M | 75.224 M | |
| Total current liabilities | 27.908 M | 33.500 M | 35.884 M | 38.135 M | 33.499 M | 40.194 M | 100.028 M | 58.506 M | |
| Accounts Payable | 7.695 M | 9.407 M | 12.534 M | 15.780 M | 11.912 M | 15.369 M | 10.384 M | 9.844 M | |
| Other liabilities | 203.000 K | 136.000 K | 13.097 M | 13.874 M | 14.756 M | 15.031 M | 11.044 M | 10.388 M | |
| Current long term debt | 2.049 M | 2.072 M | 2.545 M | 2.517 M | 2.293 M | 2.462 M | 80.772 M | 34.409 M | |
| Long term debt | 8.707 M | 8.320 M | 9.123 M | 8.655 M | 8.370 M | 7.680 M | 7.175 M | 6.330 M | |
| Other liabilities | 203.000 K | 136.000 K | 13.097 M | 13.874 M | 14.756 M | 15.031 M | 11.044 M | 10.388 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 284.734 M | 281.742 M | 249.398 M | 231.487 M | 214.756 M | 118.999 M | 96.157 M | 82.771 M | |
| Common stock | 28.555 M | 28.970 M | 29.697 M | 30.205 M | 31.498 M | 35.001 M | 39.897 M | 52.739 M | |
| Retained earnings | -278.229 M | -310.038 M | -348.715 M | -385.839 M | -424.751 M | -537.317 M | -581.208 M | -612.630 M |